1. Home
  2. KREF vs ALEC Comparison

KREF vs ALEC Comparison

Compare KREF & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KKR Real Estate Finance Trust Inc.

KREF

KKR Real Estate Finance Trust Inc.

N/A

Current Price

$5.40

Market Cap

337.4M

Sector

Real Estate

ML Signal

N/A

Logo Alector Inc.

ALEC

Alector Inc.

N/A

Current Price

$2.49

Market Cap

275.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KREF
ALEC
Founded
2014
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
337.4M
275.8M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
KREF
ALEC
Price
$5.40
$2.49
Analyst Decision
Hold
Hold
Analyst Count
6
7
Target Price
★ $7.00
$3.90
AVG Volume (30 Days)
924.6K
★ 2.0M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 7.46%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.70
Revenue
N/A
★ $21,045,000.00
Revenue This Year
$349.17
$900.51
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$3.52
Revenue Growth
★ N/A
N/A
52 Week Low
$4.94
$1.09
52 Week High
$9.11
$2.84

Technical Indicators

Market Signals
Indicator
KREF
ALEC
Relative Strength Index (RSI) 41.39 61.48
Support Level $5.09 $1.90
Resistance Level $6.01 $2.65
Average True Range (ATR) 0.34 0.23
MACD 0.02 0.04
Stochastic Oscillator 42.60 64.22

Price Performance

Historical Comparison
KREF
ALEC

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: